The dilemma of low grade glioma

Neurology in Practice

Volumn 75, Issue 2, 2004, Pages

  Whittle, I R ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

TEMOZOLOMIDE;

CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; GLIOMA; HUMAN; IMAGING SYSTEM; NEUROIMAGING; NEURORADIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; TREATMENT FAILURE; ASTROCYTOMA; GENE DELETION; MEDICAL DECISION MAKING; NEUROEPITHELIOMA; NEUROPATHOLOGY; PROGNOSIS; SEIZURE;

EID: 2442688878     PISSN: 14737086     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.2004.040501     Document Type: Review

References (17)

1. Keles GE, Lamborn KR, Berger MS. Low-grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome. J Neurosurg 2001;95:735-45.
2. Wilson CB, Bramwell V, Bonfill X, et al. Central nervous system tumours. In: Williams C, ed. Evidence-based oncology. London: BMJ, 2003:561-4.
3. Wessels PH, Weber WE, Raven G, et al. Supratentorial grade II astrocytoma: biological features and clinical course. Neurology. Lancet Neurol 2003;2:395-403.
4. Luyken C, Blumcke I, Fimmers R, et al. The spectrum of long-term epilepsy-associated tumors: long-term seizure and tumor outcome and neurosurgical aspects. Epilepsia 2003;44:822-30.
5. Ellis TL, Stieber VW, Austin RC. Oligodendroglioma. Curr Treat Options Oncol 2003;4:479-90.
6. Feigenberg SJ, Amdur RJ, Morris CG, et al. Oligodendroglioma: does deferring treatment compromise outcome? Am J Clin Pathol 2003;26:e60-6.
7. Scott JN, Brasher PM, Sevick RJ, et al. How often ore nonenhancing supratentorial gliomas malignant? A population study. Neurology 2002;59:947-9.
8. Lang FF, Olansen NE, DeMonte F, et al. Surgical resection of intrinsic insular tumors: complication avoidance. J Neurosurg 2001;95:638-50.
9. Duffau H, Capelle L, Denvil D, et al. Functional recovery after surgical resection of low grade gliomas in eloquent broin: hypothesis of brain compensation. J Neurol Neurosurg Psychiatry 2003;74:901-7.
10. Peraud A, Meschede M, Eisner W, et al. Surgical resection of grade II astrocytomas in the superior frontal gyrus. Neurosurgery 2002;50:966-75.
11. Karim AB, Maat B, Hatlevoll R, et al. A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844. Int J Rad Oncol Biol Phys 1996;36:549-56.
12. Shaw E, Arusell R, Scheithauer B, et al. Prospective randomized trial of low-versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group study. J Clin Oncol 2002;20:2267-76.
13. Karim AB, Afra D, Cornu P, et al. Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. Inf J Rad Oncol Biol Phys 2002;52:316-24.
14. Brown PD, Buckner JC, O'Fallon JR, et al. Effects of radiotherapy on cognitive function in patients with low-grade glioma measured by the folstein minimental state examination. J Clin Oncol 2003;21:2519-24.
15. Klein M, Heimans JJ, Aaronson NK, et al. Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study. Lancet 2002;360:1361-8.
16. Pignatti F, van den BM, Curran D, et al. European Organization for Research and Treatment of Cancer Brain Tumor Cooperative Group, European Organization for Research and Treatment of Cancer Radiotherapy Cooperative Group. Prognostic factors for survival in adult patients with cerebral low-grade glioma. J Clin Oncol 2002;20:2076-84.
17. Eyre HJ, Crowley JJ, Townsend JJ, et al. A randomized trial of radiotherapy versus radiotherapy plus CCNU for incompletely resected low-grade gliomas: a Southwest Oncology Group study. J Neurosurg 1993;78:909-14.